These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2831128)
1. Combined corticotropin-releasing hormone-vasopressin test: a new test for the evaluation of the pituitary adrenal system. Späth-Schwalbe E; Fehm HL; Born J; Pfeiffer EF Horm Metab Res; 1987 Dec; 19(12):665-6. PubMed ID: 2831128 [No Abstract] [Full Text] [Related]
3. Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. Liu JH; Muse K; Contreras P; Gibbs D; Vale W; Rivier J; Yen SS J Clin Endocrinol Metab; 1983 Nov; 57(5):1087-9. PubMed ID: 6311862 [TBL] [Abstract][Full Text] [Related]
4. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency. Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168 [TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor, a new aid in the diagnosis of pituitary-adrenal disorders? Hermus AR; Pieters GF; Smals AG; Kloppenborg PW Neth J Med; 1985; 28(1):2-5. PubMed ID: 2983245 [No Abstract] [Full Text] [Related]
6. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Hundt W; Zimmermann U; Pöttig M; Spring K; Holsboer F Alcohol Clin Exp Res; 2001 May; 25(5):687-91. PubMed ID: 11371718 [TBL] [Abstract][Full Text] [Related]
7. Influence of vasopressin and of a crude CRF preparation on pituitary ACTH-release in posterior-lobectomized rats. de Wied D Neuroendocrinology; 1968; 3(3):129-35. PubMed ID: 4301554 [No Abstract] [Full Text] [Related]
8. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of corticotropin release by corticotropin-releasing factor (CRF) or by vasopressin following intrapituitary infusions in unanesthetized dogs: inhibition of the responses by dexamethasone. Gonzalez-Luque A; L'age M; Dhariwal AP; Yates FE Endocrinology; 1970 May; 86(5):1134-42. PubMed ID: 4314067 [No Abstract] [Full Text] [Related]
11. [The effect of one-time stress on the reactivity of the hypophyseal-adrenal cortical system to corticotropin-releasing factor and vasopressin in rats]. Podvigina TT Ross Fiziol Zh Im I M Sechenova; 1999 Mar; 85(3):462-5. PubMed ID: 10494599 [No Abstract] [Full Text] [Related]
12. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats. Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772 [TBL] [Abstract][Full Text] [Related]
13. The hypothalamic-pituitary-adrenal axis in depression. Meltzer HY; Lowy MT; Koenig JI Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885 [No Abstract] [Full Text] [Related]
14. Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity. Vicennati V; Ceroni L; Genghini S; Patton L; Pagotto U; Pasquali R Obesity (Silver Spring); 2006 Feb; 14(2):235-43. PubMed ID: 16571848 [TBL] [Abstract][Full Text] [Related]
15. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats. Naert G; Ixart G; Tapia-Arancibia L; Givalois L Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid therapy and pituitary-adrenal responses to corticotropin-releasing hormone. Axelrod L N Engl J Med; 1992 Jul; 327(4):282-3; author reply 283-4. PubMed ID: 1614480 [No Abstract] [Full Text] [Related]
18. Glucocorticoid therapy and pituitary-adrenal responses to corticotropin-releasing hormone. Hägg E; Asplund K; Lithner F N Engl J Med; 1992 Jul; 327(4):282; author reply 283-4. PubMed ID: 1614479 [No Abstract] [Full Text] [Related]
19. Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls. Rupprecht M; Salzer B; Raum B; Hornstein OP; Koch HU; Riederer P; Sofic E; Rupprecht R Exp Clin Endocrinol Diabetes; 1997; 105(1):39-45. PubMed ID: 9088893 [TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]